These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24422988)

  • 21. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs.
    Finlay D; Vamos M; González-López M; Ardecky RJ; Ganji SR; Yuan H; Su Y; Cooley TR; Hauser CT; Welsh K; Reed JC; Cosford ND; Vuori K
    Mol Cancer Ther; 2014 Jan; 13(1):5-15. PubMed ID: 24194568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
    Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
    Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
    Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
    Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity.
    Zhao X; Sun B; Zhang J; Zhang R; Zhang Q
    Biochem Biophys Res Commun; 2016 Oct; 479(2):166-172. PubMed ID: 27562715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.
    Hahm ER; Singh SV
    Cancer Lett; 2013 Jun; 334(1):101-8. PubMed ID: 22935676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein.
    Voelkel-Johnson C; Hannun YA; El-Zawahry A
    Mol Cancer Ther; 2005 Sep; 4(9):1320-7. PubMed ID: 16170023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
    Eytan DF; Snow GE; Carlson S; Derakhshan A; Saleh A; Schiltz S; Cheng H; Mohan S; Cornelius S; Coupar J; Sowers AL; Hernandez L; Mitchell JB; Annunziata CM; Chen Z; Van Waes C
    Cancer Res; 2016 Sep; 76(18):5442-5454. PubMed ID: 27469115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.
    Kim SH; Bommareddy A; Singh SV
    Cancer Prev Res (Phila); 2011 Jun; 4(6):897-906. PubMed ID: 21411500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
    LaCasse EC; Cherton-Horvat GG; Hewitt KE; Jerome LJ; Morris SJ; Kandimalla ER; Yu D; Wang H; Wang W; Zhang R; Agrawal S; Gillard JW; Durkin JP
    Clin Cancer Res; 2006 Sep; 12(17):5231-41. PubMed ID: 16951243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
    Liu F; Liu Q; Yang D; Bollag WB; Robertson K; Wu P; Liu K
    Cancer Res; 2011 Nov; 71(21):6807-16. PubMed ID: 21911457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
    Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
    J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
    Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
    Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
    Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
    Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
    Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D
    Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
    Strekalova E; Malin D; Rajanala H; Cryns VL
    Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
    Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
    Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.
    Hehlgans S; Oppermann J; Reichert S; Fulda S; Rödel C; Rödel F
    Radiat Oncol; 2015 Sep; 10():198. PubMed ID: 26383618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
    Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.